HIV AIDS drugs’ universal access dream remains improbable: Report

In a disappointing new report jointly commissioned by the World Health Organisation (WHO), the UN's AIDS programme and UNICEF it was revealed that only one third of people worldwide who need life-saving HIV drugs are actually getting treated. Universal access to these medicines has been the theme of effort but it was seen that that targets would not be met. The report urges the poorer countries must “substantially ramp up” the funds for HIV/AIDS.

It is estimated 5.25 million people in developing counties are receiving vital antiretroviral drugs, to slow down the virus that causes AIDS. This is 1.2 million more than the past year but experts say 14.6 million people in total need treatment. The report found that just over half of pregnant women who tested positive for HIV were assessed for drug treatment - up from 34% the previous year. The rise marks a 30 percent increase over a year earlier and a 13-fold increase in six years, but another 10 million people approximately did not have such treatment in those countries. Only eight middle to low income nations -- including Cambodia, Cuba and Rwanda -- had achieved the treatment target by the end of 2009 the report says.

According to director of the WHO's HIV/AIDS department, Dr Gottfried Hirnschall, “Some countries - such as Rwanda - have shown that universal access to treatment can be achieved…Zimbabwe has increased access by 50% in the past year - despite being heavily compromised, politically and economically…And South Africa has had an incredible catch-up phase, despite being a late starter…But given those success stories, we need to sustain the momentum - and be smarter in making the case.”

At present the UNAIDS urges countries most affected by the virus should allocate between 0.5% and 3% of their government revenue to help this cause. Dr Hirnschall said, “Most of the countries that need to do this aren't yet reaching the 0.5% mark…They have to chip in their own resources and look seriously into increasing their domestic spending, to better complement external funding.”

The report says, “Millions of people are alive today as a result of investments in HIV over the past few years…Yet this evidence becomes available at a time when the global economic crisis has put the sustainability of many HIV programmes at risk…After years of considerable increases in international assistance, funding remained essentially flat over the current period.” Speaking of the developed countries Dr Hirnschall said, “There have been promising signals from some countries, who've already made pledges… It's clear things won't be easy though. We have to be strategic in explaining what's needed, and how investment can help other health and development outcomes.”

Wednesday's report urged more political pledges and funding, as agency officials set their sights on universal access in 2015.

Dr. Ananya Mandal

Written by

Dr. Ananya Mandal

Dr. Ananya Mandal is a doctor by profession, lecturer by vocation and a medical writer by passion. She specialized in Clinical Pharmacology after her bachelor's (MBBS). For her, health communication is not just writing complicated reviews for professionals but making medical knowledge understandable and available to the general public as well.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mandal, Ananya. (2020, April 03). HIV AIDS drugs’ universal access dream remains improbable: Report. News-Medical. Retrieved on November 19, 2024 from https://www.news-medical.net/news/20100929/HIV-AIDS-drugs-universal-access-dream-remains-improbable-Report.aspx.

  • MLA

    Mandal, Ananya. "HIV AIDS drugs’ universal access dream remains improbable: Report". News-Medical. 19 November 2024. <https://www.news-medical.net/news/20100929/HIV-AIDS-drugs-universal-access-dream-remains-improbable-Report.aspx>.

  • Chicago

    Mandal, Ananya. "HIV AIDS drugs’ universal access dream remains improbable: Report". News-Medical. https://www.news-medical.net/news/20100929/HIV-AIDS-drugs-universal-access-dream-remains-improbable-Report.aspx. (accessed November 19, 2024).

  • Harvard

    Mandal, Ananya. 2020. HIV AIDS drugs’ universal access dream remains improbable: Report. News-Medical, viewed 19 November 2024, https://www.news-medical.net/news/20100929/HIV-AIDS-drugs-universal-access-dream-remains-improbable-Report.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sweden exceeds UNAIDS HIV goals but faces new challenges